Reports
Sale
Global Oligonucleotide Synthesis Market Size, Share, Report: By Product: Oligonucleotides, Equipment/Synthesiser, Reagents, Services; By Application: PCR Primers, PCR Assays - Panels, Sequencing, DNA Microarrays, Fluorescence In Situ Hybridisation (FISH), Others; By End Use; Regional Analysis; Competitive Landscape; 2024-2032
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Oligonucleotide Synthesis Market Analysis
8.1 Key Industry Highlights
8.2 Global Oligonucleotide Synthesis Historical Market (2018-2023)
8.3 Global Oligonucleotide Synthesis Market Forecast (2024-2032)
8.4 Global Oligonucleotide Synthesis Market by Product
8.4.1 Oligonucleotides
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.1.4 Breakup by Type
8.4.1.4.1 Column-Based Oligos
8.4.1.4.1.1 Market Share
8.4.1.4.1.2 Historical Trend (2018-2023)
8.4.1.4.1.3 Forecast Trend (2024-2032)
8.4.1.4.2 Array-Based Oligos
8.4.1.4.2.1 Market Share
8.4.1.4.2.2 Historical Trend (2018-2023)
8.4.1.4.2.3 Forecast Trend (2024-2032)
8.4.1.5 Breakup by Nucleic Acid Type
8.4.1.5.1 DNA Oligos
8.4.1.5.1.1 Market Share
8.4.1.5.1.2 Historical Trend (2018-2023)
8.4.1.5.1.3 Forecast Trend (2024-2032)
8.4.1.5.2 RNA Oligos
8.4.1.5.2.1 Market Share
8.4.1.5.2.2 Historical Trend (2018-2023)
8.4.1.5.2.3 Forecast Trend (2024-2032)
8.4.2 Equipment/Synthesiser
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Reagents
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.4.4 Services
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2023)
8.4.4.3 Forecast Trend (2024-2032)
8.4.4.4 Based on Type
8.4.4.4.1 Oligo Synthesis
8.4.4.4.1.1 Market Share
8.4.4.4.1.2 Historical Trend (2018-2023)
8.4.4.4.1.3 Forecast Trend (2024-2032)
8.4.4.4.1.4 Based on Quantity
8.4.4.4.1.4.1 25 nmol
8.4.4.4.1.4.2 50 nmol
8.4.4.4.1.4.3 200 nmol
8.4.4.4.1.4.4 1,000 nmol
8.4.4.4.1.4.5 10,000 nmol
8.4.4.4.2 Purification
8.4.4.4.2.1 Market Share
8.4.4.4.2.2 Historical Trend (2018-2023)
8.4.4.4.2.3 Forecast Trend (2024-2032)
8.4.4.4.3 Modification
8.4.4.4.3.1 Market Share
8.4.4.4.3.2 Historical Trend (2018-2023)
8.4.4.4.3.3 Forecast Trend (2024-2032)
8.5 Global Oligonucleotide Synthesis Market by Application
8.5.1 PCR Primers
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 PCR Assays - Panels
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Sequencing
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.5.4 DNA Microarrays
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2023)
8.5.4.3 Forecast Trend (2024-2032)
8.5.5 Fluorescence In Situ Hybridisation (FISH)
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2023)
8.5.5.3 Forecast Trend (2024-2032)
8.5.6 Antisense Oligonucleotides
8.5.6.1 Market Share
8.5.6.2 Historical Trend (2018-2023)
8.5.6.3 Forecast Trend (2024-2032)
8.5.7 Others
8.6 Global Oligonucleotide Synthesis Market by End Use
8.6.1 Academic Research Institutes
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Diagnostic Laboratories
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Pharmaceutical-Biotechnology Companies
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.7 Global Oligonucleotide Synthesis Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Thermo Fisher Scientific Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Eurofins Scientific SE
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Merck KGaA
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Agilent Technologies, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Bio-Synthesis Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 LGC Biosearch Technologies
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Oligonucleotide Synthesis Market: Key Industry Highlights, 2018 and 2032
2. Global Oligonucleotide Synthesis Historical Market: Breakup by Product (USD Billion), 2018-2023
3. Global Oligonucleotide Synthesis Market Forecast: Breakup by Product (USD Billion), 2024-2032
4. Global Oligonucleotide Synthesis Historical Market: Breakup by Application (USD Billion), 2018-2023
5. Global Oligonucleotide Synthesis Market Forecast: Breakup by Application (USD Billion), 2024-2032
6. Global Oligonucleotide Synthesis Historical Market: Breakup by End Use (USD Billion), 2018-2023
7. Global Oligonucleotide Synthesis Market Forecast: Breakup by End Use (USD Billion), 2024-2032
8. Global Oligonucleotide Synthesis Historical Market: Breakup by Region (USD Billion), 2018-2023
9. Global Oligonucleotide Synthesis Market Forecast: Breakup by Region (USD Billion), 2024-2032
10. North America Oligonucleotide Synthesis Historical Market: Breakup by Country (USD Billion), 2018-2023
11. North America Oligonucleotide Synthesis Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Europe Oligonucleotide Synthesis Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Europe Oligonucleotide Synthesis Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Asia Pacific Oligonucleotide Synthesis Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Asia Pacific Oligonucleotide Synthesis Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Latin America Oligonucleotide Synthesis Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Latin America Oligonucleotide Synthesis Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Middle East and Africa Oligonucleotide Synthesis Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Middle East and Africa Oligonucleotide Synthesis Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Global Oligonucleotide Synthesis Market Structure
Key Questions Answered in the Report
In 2023, the market attained a value of nearly USD 3.04 billion.
The market is projected to grow at a CAGR of 13.1% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 9.21 billion by 2032.
The major drivers of the market include the development of new technologies, rise in demand for high end customised oligos, upgradation in the purification of synthetic oligonucleotides, acquisition of various small-scale oligonucleotide synthesis companies, and advances in enzyme failure correction technology.
Robust research and development activities and increasing investments and funding by the governments to produce innovative oligonucleotide products are the key trends propelling the market demand.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Oligonucleotides, equipment/synthesiser, reagents, and services are the significant products of oligonucleotide synthesis in the market.
The various applications of oligonucleotide synthesis are PCR primers, PCR assays-panels, sequencing, DNA microarrays, fluorescence in situ hybridisation (FISH), and antisense oligonucleotides, among others.
The several end uses of the product are academic research institutes, diagnostic laboratories, and pharmaceutical-biotechnology companies.
The major players in the market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Merck KGaA, Agilent Technologies, Inc., Bio-Synthesis Inc., and LGC Biosearch Technologies, among others.
Analyst Review
The global oligonucleotide synthesis market attained a value of USD 3.04 billion in 2023, driven by the rising research and development expenditure. Aided by the investments and fundings by the government, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 13.1%. The market is projected to reach USD 9.21 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of product, the market is divided into oligonucleotides, equipment/synthesiser, reagents, and services. Based on application, the oligonucleotide synthesis industry can be segmented into PCR primers, PCR assays-panels, sequencing, DNA microarrays, fluorescence in situ hybridisation (FISH), and antisense oligonucleotides, among others. On the basis of end use, the market is classified into academic research institutes, diagnostic laboratories, and pharmaceutical-biotechnology companies. The major regional markets for oligonucleotide synthesis are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Thermo Fisher Scientific Inc., Eurofins Scientific SE, Merck KGaA, Agilent Technologies, Inc., Bio-Synthesis Inc., and LGC Biosearch Technologies, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER